Back to search

Article

Development of Nucleocapsid-Specific Monoclonal Antibodies for SARS-CoV-2 and Their ELISA Diagnostics on an Automatic Microfluidic Device

2022-06-17

Abstract excerpt

Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has threatened public health globally, and the emergence of viral variants has exacerbated an already precarious situation. To prevent further spread of the virus and determine government action required for virus control, accurate and rapid immunoassays for SARS-CoV-2 diagnosis are urgentl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a1b17616-4a0e-5dc4-8bfa-cd3fdd243cbe
DOI
10.2139/ssrn.4136033
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development of Nucleocapsid-Specific Monoclonal Antibodies for SARS-CoV-2 and Their ELISA Diagnostics on an Automatic Microfluidic DeviceDOI 10.2139/ssrn.4136033
Highly Specific Monoclonal Antibodies Against SARS-CoV-2 Nucleocapsid Antigen for Accurate Diagnosis of COVID-19Semantic proximity
The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay deviceSemantic proximity
Preparation of highly specific monoclonal antibodies against SARS-CoV-2 nucleocapsid protein and the preliminary development of antigen detection test strips.Semantic proximity
Development of Monoclonal Antibodies Against SARS-CoV-2 Nucleocapsid Protein for COVID-19 Antigen DetectionSemantic proximity
Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants.Semantic proximity
Development and Clinical Evaluation of a Rapid Antibody Lateral Flow Assay for the Diagnosis of SARS-CoV-2 InfectionSemantic proximity
Gold Nanoparticle-Based Colorimetric and Fluorescent Dual-Mode Lateral Flow Immunoassay for SARS-CoV-2 DetectionSemantic proximity
Detection and identification of SARS-CoV-2 and influenza a based on microfluidic technologySemantic proximity
Centrifugal microfluidic-based multiplex recombinase polymerase amplification assay for rapid detection of SARS-CoV-2Semantic proximity
Nano assembly of plasmonic probe-virus particles enabled rapid and ultrasensitive point-of-care SARS-CoV-2 detectionSemantic proximity
A high-throughput microfluidic nano-immunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultra-low volume dried blood samplesSemantic proximity
Simultaneous detection of SARS-CoV-2 and influenza A/B viruses on an electromagnetically-driven, integrated microfluidic systemSemantic proximity
Select a neighboring publication to make it the new centre.